CompaniesMolecular Templates

Molecular Templates

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (10)
View all

Total Trials

10

As Lead Sponsor

9

As Collaborator

1

Total Enrollment

198

By Phase

PHASE1: 5PHASE2: 3PHASE1/PHASE2: 1

By Status

TERMINATED: 7WITHDRAWN: 2NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT02361346
NCT03488251
NCT03645395
NCT04029922
NCT04017130
NCT04795713
NCT04757090
Hover over trial bars to see details

Recent Trials

NCT06034860Lead Sponsor
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
PHASE1Terminated
15 participants
Started: Nov 1, 2023 · Completed: Oct 31, 2024
NCT04757090Collaborator
89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111
PHASE2Withdrawn
Started: Dec 31, 2021 · Completed: Dec 31, 2023
NCT04795713Lead Sponsor
Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1
PHASE1Terminated
64 participants
Started: May 27, 2021 · Completed: Oct 31, 2024
NCT04017130Lead Sponsor
A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1Terminated
14 participants
Started: Feb 5, 2020 · Completed: Dec 13, 2023
NCT04029922Lead Sponsor
Study of MT-5111 in HER2-positive Solid Tumors
PHASE1Terminated
50 participants
Started: Nov 12, 2019 · Completed: Apr 27, 2023
View all 10 trials →
Funding History (3)
D
Jul 2, 2014
Filing
D
Apr 15, 2011
Filing
D
Apr 2, 2009
Filing